Equity Analysis

Quarterly Results

    Lactose (India) Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs
    BSE Code
    ISIN Demat
    Book Value()
    524202
    INE058I01013
    55.0086592
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    N.A
    30.77
    286.99
    EPS(TTM)
    Face Value()
    Div & Yield %:
    6.62
    10
    0
     
Quarters
(RupeeIcon Cr)
ParticularsSep 2024Jun 2024Mar 2024
Gross Sales30.4529.4629.40
Other Operating Income0.000.000.00
Other Income 0.300.220.31
Total Income30.7529.6829.70
Total Expenditure 25.4323.8923.29
PBIDT5.315.796.41
Interest 1.371.261.16
PBDT3.944.545.26
Depreciation1.331.311.63
Tax0.440.540.56
Fringe Benefit Tax0.000.000.00
Deferred Tax0.140.420.67
Reported Profit After Tax2.032.272.40
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item2.032.272.40
EPS (Unit Curr.)1.611.801.91
EPS (Adj) (Unit Curr.)1.611.801.91
Calculated EPS (Unit Curr.)1.611.801.91
Calculated EPS (Adj) (Unit Curr.)1.611.801.91
Calculated EPS (Ann.) (Unit Curr.)6.467.217.62
Calculated EPS (Adj) (Ann.) (Unit Curr.)6.467.217.62
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity12.5912.5912.59
Reserve & Surplus0.000.000.00
Face Value10.0010.0010.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)17.4419.6521.80
PBDTM(%)12.9415.4117.89
PATM(%)6.677.718.16
Dividend Per Share(Rs)0.000.000.00
Diluted EPS1.611.801.91